ecancer travels so that you don't have to. Explore the latest conference coverage in global oncology and find out where we are going next.
26 - 29 Jun 2010
Palazzo dei Congressi, Florence, Italy
The role of ECCO in European oncopolicy
Prof Julio Celis - Institute of Cancer Biology, Copenhagen, Denmark
The role of the B-RAF mutation in melanoma treatment
Prof Richard Marais - Institute of Cancer Research, London, UK
The role of tumour suppressor cells in the prevention of cancer
Prof Arnold Levine - Cancer Institute of New Jersey, USA
The development of novel targets for cancer therapy
Prof Kristian Helin - University of Copenhagen, Denmark
The role of epigenetics in cancer therapy
Prof Manel Esteller - Cancer Epigenetics and Biology Programme (PEBC), Barcelona...
Predicting the response of breast cancer to systemic therapy
Prof Marc van de Vijver - Academic Medical Centre, Amsterdam, Netherlands
The role of homologous recombination in cancer
Prof Thomas Helleday - Gray Institute for Radiation Oncology & Biology, Oxford, ...
Genetic susceptibility to cancer
Dr Allan Balmain - UCSF, San Francisco, USA
The potential of epigenetics in cancer treatment
Dr Peter Jones - University of Southern California, USA
Determinants of outcome in breast cancer patients
Prof Carlos Caldas - University of Cambridge, UK